Effects of exercise and stress management training on nighttime blood pressure dipping in patients with coronary heart disease: A randomized, controlled trial by Sherwood, Andrew et al.
Effects of Exercise and Stress Management Training on 
Nighttime Blood Pressure Dipping in Patients with Coronary 
Heart Disease: A Randomized Controlled Trial
Andrew Sherwood, PhDa, Patrick J. Smitha, Alan L. Hinderliter, MDb, Anastasia Georgiades, 
PhDa, and James A. Blumenthal, PhDa
aDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, 
NC, USA
bDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA
Abstract
INTRODUCTION—Blunted nighttime blood pressure (BP) dipping is prognostic of 
cardiovascular morbidity and mortality. Patients with coronary heart disease (CHD) are often 
characterized by a blunted nighttime BP dipping pattern. The present study compared the effects 
of two behavioral intervention programs, aerobic exercise (EX) and stress management (SM) 
training, with a usual care (UC) control group on BP dipping in a sample of CHD patients.
METHODS—This was a secondary analysis of a randomized controlled trial with allocation 
concealment and blinded outcome assessment in 134 patients with stable CHD and exercise-
induced myocardial ischemia. Nighttime BP dipping was assessed by 24-hour ambulatory blood 
pressure monitoring (ABPM), at pre-randomization baseline and following 16 weeks of one of the 
following treatments: usual medical care; usual care plus supervised aerobic exercise for 35 min 3 
times per week; usual care plus weekly 1.5 hr sessions of stress management training.
RESULTS—The EX and SM groups exhibited greater improvements in SBP dipping (P = .052) 
and DBP dipping (P = .031) compared with UC. Post intervention SBP percent-dipping means 
were 12.9 (SE = 1.5) for SM, 11.1 (SE = 1.4) for EX, and 8.6 (SE = 1.4) for UC. Post intervention 
DBP percent-dipping means were 13.3 (SE = 1.9) for SM, 14.1 (SE = 1.8) for EX, and 8.8 (1.8) 
for UC.
CONCLUSIONS—For patients with stable CHD, exercise or stress management training resulted 
in improved nighttime BP dipping compared to usual medical care. These favorable effects of 
healthy lifestyle modifications may help reduce the risk of adverse clinical events.
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INTRODUCTION
Blunted nighttime blood pressure (BP) dipping, typically defined as <10% fall in average BP 
from daytime to nighttime, is a strong prognostic indicator of cardiovascular morbidity and 
mortality for both hypertensive and non-hypertensive individuals1–4. Blunted nighttime BP 
dipping also appears to be unusually common in patients with coronary heart disease 
(CHD), with a non-dipping pattern approximately twice as common as in age-matched 
controls.5–7 For vulnerable CHD patients, blunted nighttime BP dipping may exacerbate 
their heightened risk of adverse cardiovascular disease (CVD) events. As a result, there have 
been a number of different approaches designed to enhance BP dipping in various CVD 
populations.
Chronotherapy is one successful approach to enhancing nighttime BP dipping. For patients 
with hypertension, bedtime dosing of antihypertensive medications, rather than typical 
morning dosing, lowers nighttime BP8–10. Nighttime dosing of melatonin, a hormone 
involved in diurnal regulation, also may enhance BP dipping through multiple physiological 
pathways11. Lifestyle factors including physical activity and psychological stress also affect 
the nocturnal decline in BP. For example, greater daytime physical activity has been related 
to enhanced nighttime BP dipping12, but the evidence is equivocal with regard to whether 
dipping is improved with exercise training 13–16. Psychological stress also has been linked to 
a blunted fall in nighttime BP17, suggesting that behavioral interventions designed to reduce 
stress may also enhance dipping. However, to our knowledge, no study to date has evaluated 
whether stress reduction may improve BP dipping in CHD patients. The present report from 
the Smart Heart trial18 examined the effects of a 16-week stress management (SM) 
intervention and aerobic exercise (EX) compared to Usual Care (UC) on nighttime BP 
dipping in patients with CHD. The primary results of the trial, which showed that both active 
interventions improved biomarkers of cardiovascular risk, have been reported previously.18 
To assess BP dipping, 24-hour ABPM was performed before and after the interventions. We 




This is a secondary analysis of the Smart Heart trial of 134 patients with CHD and exercise-
induced myocardial ischemia. Primary outcomes, including stress-induced myocardial 
ischemia, CVD biomarkers, and measures of general distress have been reported 
previously.19 This report focuses on 24-hour ABPM data that have not been reported 
previously. The study was conducted from January 199 through February 2003. The study 
was supported by grants HL59672 and M01-RR-30 from the National Institutes of Health. 
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The authors are solely responsible for the design and conduct of this study, all study 
analyses, the drafting and editing of the paper and its final contents.
Participants
The patient sample consisted of 134 patients (92 male; 42 female), age 40–84 years (mean 
age 62 ± 10 years), with documented CHD, and evidence of exercise-induced myocardial 
ischemia. This study was approved by the Institutional Review Board at Duke University 
Medical Center and written informed consent was obtained from all participants prior to 
their participation.
Procedures
24-Hour Ambulatory Blood Pressure Monitoring—ABPM was conducted during a 
typical workday. The AccuTracker II ABP Monitor (Suntech, Raleigh, NC) was worn for 
approximately 24 hours, usually starting between 8:00 AM and 10:00 AM until the same 
time the following morning. The AccuTracker II, which measures BP noninvasively based 
on the auscultatory technique, has been validated for accuracy.20–22 It was programmed to 
take 3 BP measurements per hour at random intervals during daytime hours, and 2 readings 
per hour during the participant’s anticipated nighttime sleep period. Participants were 
instructed to follow their normal daily schedule. Mean SBP and DBP values were computed 
based on all valid readings obtained during waking hours and during nighttime sleep 
(defined by the participants’ retrospective reports of when they turned out room lights at 
bedtime to the time they got out of bed the following morning). SBP and DBP dipping were 
computed as continuous variables, defined as percent change from mean waking BP to mean 
nighttime sleep BP.
Medications—Because the focus of the parent trial18 was on mental stress-induced 
myocardial ischemia, unless medically contraindicated, patients discontinued their use of 
anti-ischemic medications, including beta-blockers, calcium channel blockers, and long-
lasting nitrates for 48 hours prior to their baseline and post-intervention ABPM assessments. 
Twenty-eight participants could not safely discontinue their anti-ischemic medications, and 
those that did discontinue them did so for ≤ 3 days. Most participants were taking a daily 
low-dose aspirin and lipid lowering drugs. There were no group differences in medication 
usage, which was described in detail in the primary publication.18
Interventions—Once patients completed their baseline ABPM assessments, they resumed 
their usual medical management on anti-ischemic medications. Importantly, participants 
were taking the same medications for their baseline and post-intervention 24-hour ABPM 
study. Using block randomization, patients were randomly assigned to one of three treatment 
conditions.
Exercise training (EX): Patients assigned to the aerobic exercise condition exercised 3 
times per week for 16 consecutive weeks. Exercise sessions consisted of a 10 minute warm 
up period involving stretching and exercise on a stationary bicycle at a heart rate of 50–70% 
heart rate reserve followed by 35 minutes of walking and jogging at a target intensity of 70–
85% heart rate reserve.
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Stress Management training (SM): The SM training program was based upon our prior 
work23, which emphasizes a cognitive-social learning model of behavior. The interaction of 
the social environment with personality traits that predispose individuals to respond to 
situations in particular ways was highlighted, and the treatment program was based upon the 
notion that emotion and behavior are largely determined by individuals’ cognitive 
perceptions. The program consisted of 16 weekly 1.5 hour sessions conducted in a group 
setting with 6–8 patients per group. Three key components of the intervention included 
education, coping skills training, and social support. Participants were provided information 
about CHD, the structure and function of the heart, traditional risk factors, and emotional 
stress. Stress was considered to be an imbalance between excessive demands and inadequate 
coping skills. The coping skills training aspect of the intervention included instruction in 
specific skills to reduce the affective, behavioral, cognitive, and physiologic components of 
stress. Therapeutic techniques included graded task assignments, monitoring irrational 
automatic thoughts, and generating alternative interpretations of situations or unrealistic 
thought patterns. Patients were instructed in progressive muscle relaxation and imagery 
techniques, along with training in assertiveness, problem solving, and time management. 
Role playing also was utilized. Finally, group interaction and social support were 
encouraged.
Usual Care (UC): Patients in the UC condition were monitored on a monthly basis to 
ensure that they had not joined any exercise or stress management training program. Patients 
were maintained on their regular medical regimens and saw their local cardiologists as 
needed. No attempt was made to in any way to alter the usual care that these patients 
received from their personal physicians.
Statistical Analysis
Treatment group effects for BP dipping were evaluated using general linear models through 
SAS 9.2 (PROC GLM, SAS Institute, Cary, NC). All models included pre-randomization 
baseline values of the outcome variable, gender, and ethnicity. Analyses of treatment effects 
followed the intention-to-treat (ITT) principle, with post-treatment missing data managed 
using Markov chain Monte Carlo multiple imputation methods available in SAS (PROC MI) 
and 1000 imputations. Planned, orthogonal contrasts were conducted comparing 1) both 
active treatment groups (EX and SM) vs. UC and 2) the EX and SM groups. We evaluated 
the extent to which models met assumptions, including additivity, linearity, and distribution 
of residuals. We found no evidence of significant violations of these assumptions.
RESULTS
One hundred and thirty-four individuals were randomized to participate in the intervention 
including 44 to SM, 48 to EX, and 42 to UC, as previously reported (Table 1).18 The flow of 
participants from recruitment through post-intervention assessments is illustrated in Figure 
1.
We did not observe any baseline imbalance in daytime or nighttime ambulatory BPs (all 
p’s>.774), SBP dipping (P = .853), or DBP dipping (P = .951). At baseline, 124 participants 
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provided BP dipping data. Of these 64 (52%) were considered ‘dippers’ (≥ 10% mean SBP 
dip from daytime to nighttime).
Nocturnal Blood Pressure Dipping Changes
Examination of planned treatment contrasts demonstrated that the EX and SM groups 
exhibited a strong trend towards greater improvements in SBP dipping compared with the 
UC condition (P = .052). SBP dipping improvements from pre-to post-treatment were 3.2 
(SE = 1.5) % for SM, 1.7 (SE = 1.5) % for EX, and −0.7 (SE = 1.4) % for UC (Table 2). As 
shown in Figure 2, this corresponded to mean post-treatment SBP dipping values of 12.9 
(SE = 1.5) % for SM, 11.1 (SE = 1.4) % for EX, and 8.6 (1.4) % for UC.
Examination of changes in DBP dipping demonstrated a similar pattern of findings, with the 
treatment groups demonstrating greater improvements in DBP dipping compared with the 
UC condition (P = .031). DBP dipping improvements from pre-to post-treatment were 1.2 
(SE = 1.9) % for SM, 2.5 (SE = 1.9) % for EX, and −3.0 (SE = 1.8) % for UC, 
corresponding to mean post-treatment DBP dipping values of 13.2 (SE = 1.9) % for SM, 
14.0 (SE = 1.9) % for EX, and 8.8 (1.8) % for UC (Figure 2; Table 2).
Daytime Blood Pressure Changes
Examination of average daytime SBP revealed no overall change from baseline to post-
intervention (P=.272), and treatment groups did not differ following the interventions (P = .
673), with post-treatment values of 131.1 (1.7) mm Hg for SM, 130.5 (1.7) mm Hg for EX, 
and 130.1 (1.6) mm Hg for UC. A similar non-significant pattern was noted for DBP (P = .
887), with post-treatment daytime DBP values of 74.6 (1.0) mm Hg for SM, 73.9 (0.9) mm 
Hg for EX, and 74.6 (0.9) mm Hg for UC (Table 2).
Nighttime Blood Pressure Changes
Examination of mean nighttime SBP revealed that treatment groups did not differ 
significantly following treatment (P = .305), with post-treatment nighttime SBP values of 
114.2 (2.4) mm Hg for SM, 116.1 (2.3) mm Hg for EX, and 118.8 (2.3) mm Hg for UC. In 
contrast, nighttime DBP values were lower in the treatment groups compared with UC 
controls (P = .038), with values of 64.6 (1.6) mm Hg for SM, 63.5 (1.5) mm Hg for EX, and 
68.0 (1.5) mm Hg for UC (Table 2).
DISCUSSION
Few studies have examined nighttime BP dipping in patients with CHD. Mousa and 
colleagues first described this phenomenon in a study of 68 men with documented CHD who 
exhibited a significantly blunted nighttime BP dipping compared to 68 age-matched healthy 
men.5 Our prior work described similar findings in a study comparing 54 postmenopausal 
women with documented CHD with 48 age-matched control women.6 Most recently, in a 
study of 401 patients with CVD, including those with CHD and others who had experienced 
an ischemic stroke, Cai et al. reported that blunted nighttime BP dipping was related to 
greater risk of a cardiovascular event.7 The present study provides further evidence that 
patients with CHD are prone to exhibit a non-dipping nighttime BP pattern, potentially 
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placing them at higher risk for adverse CVD events. In this sample, almost half of subjects 
were considered ‘non-‘dippers’ (≥ 10% mean SBP dip from daytime to nighttime). The 
present findings also demonstrate that two behavioral interventions, exercise and stress 
management training, may augment nighttime BP dipping, which may help reduce the risk 
of adverse CVD events associated with blunted BP dipping.
Because sleep quality is directly related to the magnitude of nighttime BP dipping 6, 24–26, 
one mechanism by which both the exercise and stress management training interventions 
may have enhanced BP dipping is by improving sleep quality. This possibility is supported 
by our finding that augmentation of nighttime BP dipping was achieved through post-
intervention declines in nighttime BP, with little changing in daytime BP. No clinical trials 
have evaluated the effects of sleep medications on nighttime BP dipping. Nighttime dosing 
of melatonin, however, a hormone involved in diurnal regulation, appears to enhance 
nighttime BP dipping, possibly in part by improving sleep quality11. Stress is considered to 
be one of the most common causes of insomnia,27 and exercise training may be an effective 
treatment for insomnia in a variety of patient populations.28–30 As previously reported, 
participants in the present study who underwent stress management or exercise training 
showed a reduction in psychological distress,18 which may have had a beneficial effects on 
their sleep quality.
These findings provide further evidence for the value of stress management and exercise 
training in improving cardiovascular health, and support previous reports that increased 
levels of physical activity may benefit BP dipping. 14–16 The mechanisms by which exercise 
may promote lower nighttime BP and augmented BP dipping have yet to be elucidated. Both 
exercise and stress management training have been shown to produce favorable changes in 
physiological regulatory systems, including improved vascular endothelial vasodilatory 
function.19 Interestingly, impaired endothelial function has been linked both to nighttime 
hypertension and insomnia31, 32. Although exercise did not result in improved heart rate 
variability (HRV) measured during supine deep breathing, stress management training did 
improve HRV compared to Usual Care.19 Reduced HRV is indicative of low 
parasympathetic activity, and has been associated with blunted nighttime BP dipping.33 In 
contrast, reduced resting sympathetic activity is related to enhanced nighttime BP 
dipping.24, 26, 34
The present study has several limitations. These include a relatively small sample size for a 
clinical trial that was not powered specifically to examine the effects of exercise and stress 
management training on nighttime BP dipping. Due in part to the sample size limitation, the 
study was not designed to address mechanisms responsible for intervention effects on BP 
dipping. Nonetheless, our observations suggest that over the course of 16-weeeks, two 
behavioral interventions, exercise and stress management training, can enhance nighttime 
BP dipping in CHD patients, who are both prone to exhibit blunted dipping and are at 
heightened risk of adverse clinical events.
Enhancing nocturnal blood pressure dipping by pharmacological chronotherapy has been 
shown to reduce subsequent cardiovascular events9. A small sub-study of the HOPE trial 
first showed that nighttime dosing of Ramipril reduced cardiovascular morbidity and 
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mortality in patients with peripheral arterial disease35. The MAPEC trial subsequently 
provided compelling evidence that in patients with hypertension, restoration of a normal 
nighttime “dipper” profile reduced the risk of CVD, stroke and new onset diabetes36. 
Nighttime dosing of antihypertensive medications typically augments BP dipping by 
lowering nighttime BP. Compared to usual care controls, this same phenomenon was evident 
for DBP dipping for the behavioral interventions. Because both exercise and stress 
management training improved other biomarkers of CVD risk, in addition to nighttime BP 
dipping, and also reduced psychological distress, these behavioral interventions also should 
reduce the risk for worse CHD outcomes 18. For exercise training, the supportive evidence is 
already compelling, and recent evidence indicates that enhancing traditional cardiac 
rehabilitation with stress management training can further reduce risk of adverse clinical 
events in cardiac patients.37
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Flow of participants from initial recruitment to end of treatment. SM = Stress Management 
training; EX = Exercise training; UC = Usual Care; ITT = intention-to-treat.
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Post-intervention nighttime systolic (SBP) and diastolic (DBP blood pressure dipping (%) 
following 16 weeks of Exercise (EX) training, Stress Management (SM) training, and Usual 
Care (UC).
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Table 1
Background Characteristics of the Study Sample
Variable UC (n = 42) EX (n = 48) SM (n = 44) Total Cohort (n = 134)
Age, yrs. (SD) 63 (9.0) 62 (10.5) 63 (11.5) 63 (10.3)
Female N (%) 10 (24) 17 (35) 15 (34) 42 (31)
Caucasian N (%) 32 (76) 36 (75) 35 (80) 103 (77)
BMI, kg/m2 (SD) 29.8 (4.0) 29.9 (5.7) 29.0 (5.0) 29.8 (5.0)
Clinic SBP, mmHg (SD) 137.1 (20.8) 138.1 (20.0) 135.2 (17.9) 136.8 (19.5)
Clinic DBP, mmHg (SD) 78.1 (9.7) 76.8 (6.5) 75.6 (9.7) 76.8 (8.7)
Daytime SBP, mm Hg (SD) 127.9 (14.9) 127.9 (12.3) 128.5 (14.1) 128.1 (13.6)
Daytime DBP, mm Hg (SD) 74.6 (10.9) 73.8 (7.3) 74.1 (8.5) 74.1 (8.9)
Nighttime SBP, mm Hg (SD) 115.2 (17.8) 115.1 (12.9) 117.3 (15.1) 115.8 (15.2)
Nighttime DBP, mm Hg (SD) 65.9 (12.1) 64.7 (8.9) 65.3 (8.9) 65.3 (9.8)
SBP Dip, % (SD) 10.0 (7.7) 9.6 (7.8) 9.0 (7.6) 9.5 (7.7)
DBP Dip, % (SD) 11.5 (8.8) 12.0 (9.1) 12.0 (8.6) 11.8 (8.8)
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Table 2
Post intervention ambulatory blood pressures following 16 weeks of Exercise (EX) training, Stress 
Management (SM) training, and Usual Care (UC).
UC (N = 42) EX (N = 48) SM (N = 44)
Daytime SBP (mm Hg) 130 ± 2 131 ± 2 132 ± 2
Nighttime SBP (mm Hg) 119 ± 2 117 ± 2 115 ± 2
SBP Dip (%) 9 ± 1 11 ± 1 13 ± 2
Daytime DBP (mm Hg) 75 ± 1 74 ± 1 75 ± 1
Nighttime DBP (mm Hg) 68 ± 1 64 ± 1 65 ± 1
DBP Dip (%) 9 ± 2 14 ± 2 13 ± 2
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